RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET)
Publication
, Conference
Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D
Published in: NEURO-ONCOLOGY
June 1, 2018
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 1, 2018
Volume
20
Start / End Page
104 / 104
Location
Denver, CO
Publisher
OXFORD UNIV PRESS INC
Conference Name
18th International Symposium on Pediatric Neuro-Oncology (ISPNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gururangan, S., Grant, G., Driscoll, T., Archer, G., Herndon, J., Friedman, H., … Mitchell, D. (2018). RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET). In NEURO-ONCOLOGY (Vol. 20, pp. 104–104). Denver, CO: OXFORD UNIV PRESS INC.
Gururangan, Sridharan, Gerald Grant, Tim Driscoll, Gerald Archer, James Herndon, Henry Friedman, Joanne Kurtzberg, Darell Bigner, John Sampson, and Duane Mitchell. “RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET).” In NEURO-ONCOLOGY, 20:104–104. OXFORD UNIV PRESS INC, 2018.
Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, et al. RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET). In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 104–104.
Gururangan, Sridharan, et al. “RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET).” NEURO-ONCOLOGY, vol. 20, OXFORD UNIV PRESS INC, 2018, pp. 104–104.
Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, Kurtzberg J, Bigner D, Sampson J, Mitchell D. RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 104–104.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 1, 2018
Volume
20
Start / End Page
104 / 104
Location
Denver, CO
Publisher
OXFORD UNIV PRESS INC
Conference Name
18th International Symposium on Pediatric Neuro-Oncology (ISPNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis